thujaplicatin methyl ether
(3S-trans)-dihydro-3-((4-hydroxy-3,5-dimethoxyphenyl)methyl)-4-((4-hydroxy-3-methoxyphenyl)methyl)-2(3H)-furanone
Identification
| Name | thujaplicatin methyl ether |
| IUPAC | (3S,4S)-3-[(4-hydroxy-3,5-dimethoxyphenyl)methyl]-4-[(4-hydroxy-3-methoxyphenyl)methyl]oxolan-2-one |
| CAS Number | 6512-67-0 |
| FDA UNII | 2VJD5SJF7V |
| Molecular Formula | C21 H24 O7 |
| Molecular Weight | 388.41668000 |
| Nikkaji Number | J1.790.162A |
Regulatory
Physical Properties
| Assay | 95.00 to 100.00 |
| Food Chemicals Codex Listed | No |
| Soluble in | water, 46.88 mg/L @ 25 °C (est) |
No sensory data available
Safety Information
| Oral/Parenteral Toxicity | Not determined |
| Dermal Toxicity | Not determined |
| Inhalation Toxicity | Not determined |
GHS Classification
['GHS Classification in accordance with 29 CFR 1910 (OSHA HCS)', 'GHS Label elements, including precautionary statements']
Safety in Use
| Category | natural substances and extractives |
| Recommendation for thujaplicatin methyl ether usage levels up to | not for fragrance use. |
| Recommendation for thujaplicatin methyl ether flavor usage levels up to | not for flavor use. |
No supplier data available
Potential Uses
Natural Occurrence
Synonyms
(3S-trans)-
dihydro-3-((4-hydroxy-3,5-dimethoxyphenyl)methyl)-4-((4-hydroxy-3-methoxyphenyl)methyl)-2(3H)-furanone
2(3H)-
furanone, dihydro-3-((4-hydroxy-3,5-dimethoxyphenyl)methyl)-4-((4-hydroxy-3-methoxyphenyl)methyl)-, (3S-trans)-
(3S,4S)-3-[(4-
hydroxy-3,5-dimethoxyphenyl)methyl]-4-[(4-hydroxy-3-methoxyphenyl)methyl]oxolan-2-one
PubMed:
Cytotoxic activity of Ipomoea cairica.
PubMed:
Analysis of western redcedar (Thuja plicata Donn) heartwood components by HPLC as a possible screening tool for trees with enhanced natural durability.
PubMed:
[The chemical proof of the absolute configurations of di-o-methylhydroxy-thujaplicatin methyl ether, pluviatolide and 2-(3'',4''-dimethoxybenzyl)-3(3', 4'-methylenedioxybenzyl) butyrolactone (author's transl)].
PubMed:
[The absolute configurations of thujaplicatin methyl ether and 2-(3,4,5-trimethoxybenzyl)-3-(3,4-methylenedioxybenzyl)butyrolactone (author's transl)].